Changes to Commission Decision of 8 May 2007 allowing Member States to extend provisional authorisations granted for the new active substances benalaxyl-M, fluoxastrobin, prothioconazole, spirodiclofen, spiromesifen and sulfuryl fluoride (notified under document number C(2007) 1929) (2007/333/EC)

EU Decision 2007/333

Made by Commission Decision of 29 July 2009 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, benalaxyl-M, mandipropamid, novaluron, proquinazid, spirodiclofen and spiromesifen (notified under document number C(2009) 5582) (2009/579/EC)

1 change. All changes to Commission Decision of 8 May 2007 allowing Member States to extend provisional authorisations granted for the new active substances benalaxyl-M, fluoxastrobin, prothioconazole, spirodiclofen, spiromesifen and sulfuryl fluoride (notified under document number C(2007) 1929) (2007/333/EC)

From legislation.gov.uk's record of changes, the official one: see it there.

Data

• JSON